Page last updated: 2024-11-05

thiotepa and Bone Marrow Neoplasms

thiotepa has been researched along with Bone Marrow Neoplasms in 5 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Bone Marrow Neoplasms: Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bregni, M1
Fleischhauer, K1
Bernardi, M1
Pescarollo, A1
Guggiari, E1
Lunghi, F1
Deola, S1
Scaramuzza, S1
Re, F1
Setola, E1
Monari, M1
Mazzi, B1
Servida, P1
Corradini, P1
Peccatori, J1
Walterhouse, DO1
Hoover, ML1
Marymont, MA1
Kletzel, M1
Foa, C1
Magné, N1
Bondiau, PY1
Otto, J1
Thyss, A1
Kushner, BH1
Meyers, PA1
Hertzberg, H1
Kremens, B1
Velten, I1
Beck, JD1
Greil, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Assessment of MGMT Promoter Methylation and Clinical Benefit From Temozolomide-based Therapy in Ewing Sarcoma Patients[NCT03542097]82 participants (Actual)Observational2014-04-15Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for thiotepa and Bone Marrow Neoplasms

ArticleYear
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-01, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neopl

2001

Other Studies

4 other studies available for thiotepa and Bone Marrow Neoplasms

ArticleYear
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
    Bone marrow transplantation, 2006, Volume: 37, Issue:3

    Topics: Adult; Biomarkers, Tumor; Bone Marrow; Bone Marrow Neoplasms; Bone Marrow Transplantation; Breast Ne

2006
High-dose chemotherapy followed by peripheral blood stem cell rescue for metastatic rhabdomyosarcoma: the experience at Chicago Children's Memorial Hospital.
    Medical and pediatric oncology, 1999, Volume: 32, Issue:2

    Topics: Adolescent; Bone Marrow Neoplasms; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide;

1999
High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
    Bone marrow transplantation, 2000, Volume: 26, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Busulfan; Carboplatin;

2000
Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2001, Volume: 27, Issue:6

    Topics: Antigens, CD34; Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; Carboplatin; Child; Cy

2001